Paper3877902
A limiting dilution assay for quantifying Leishmania major in tissues of infected mice.
Titus RG and 3 others. Parasite Immunol, 1985. Cited by 471 papers, by iCite.
Cite this record
ConductScience Library. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Papers, record 3877902. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3877902
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leishmania tropica | Major topic |
| Leishmaniasis | Major topic |
| Animals | |
| Immunization, Passive | |
| Lymph Nodes | |
| Methods | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred CBA | |
| T-Lymphocytes | |
| Time Factors |
Source PubMed
Cited by230
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 471 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943615 | Transferosome Delivery Unlocks the Therapeutic Potential of Imiquimod for Experimental Cutaneous Leishmaniasis. | Microorganisms | 2026 | https://conductscience.org/library/papers/42943615 | PubMed |
| 42924509 | Perillic Acid Synergizes With the Miltefosine Leishmanicidal Effect Against Leishmania amazonensis. | Parasite Immunol | 2026 | https://conductscience.org/library/papers/42924509 | PubMed |
| 42375405 | Mucosal delivery of pleurotus-based ISCOMATRIX elicits humoral and cellular immunity against pneumococcal infection. | Open Vet J | 2026 | https://conductscience.org/library/papers/42375405 | PubMed |
| 41926379 | Glycosomal Aquaglyceroporin 1 dual role in iron homeostasis and antimony susceptibility in Leishmania amazonensis. | PLoS Negl Trop Dis | 2026 | https://conductscience.org/library/papers/41926379 | PubMed |
| 41858624 | Platelet DKK1 promotes tolerogenic dendritic cells and non-healing responses in cutaneous leishmaniasis. | iScience | 2026 | https://conductscience.org/library/papers/41858624 | PubMed |
| 41805192 | Guanylate-binding proteins balance iNOS/Arg-1 in myeloid cells during L. major infection and promote host defense to infection. | mBio | 2026 | https://conductscience.org/library/papers/41805192 | PubMed |
| 41743710 | Long pentraxin 3 (PTX3) regulates IL-17A-mediated immunity to Leishmania major infection in mice. | Front Immunol | 2026 | https://conductscience.org/library/papers/41743710 | PubMed |
| 41559517 | Protective Effects of rLPG3 Plus Freund's Incomplete Adjuvant on Parasitism, Hepatic Function, and Immune Modulation in Experimental Visceral Leishmaniasis. | ACS Infect Dis | 2026 | https://conductscience.org/library/papers/41559517 | PubMed |
| 40872500 | Indazole Derivatives Against Murine Cutaneous Leishmaniasis. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40872500 | PubMed |
| 40720541 | Impact of co-infection with Plasmodium berghei ANKA in Leishmania major-parasitized mice on immune modulation and cutaneous leishmaniasis. | PLoS Negl Trop Dis | 2025 | https://conductscience.org/library/papers/40720541 | PubMed |
| 40655011 | Dysregulated lymphatic remodeling promotes immunopathology during non-healing cutaneous leishmaniasis. | bioRxiv | 2025 | https://conductscience.org/library/papers/40655011 | PubMed |
| 40620695 | PubChem BioAssays 1063: A Poorly Exploited Source of New Antileishmanial Compounds. | J Parasitol Res | 2025 | https://conductscience.org/library/papers/40620695 | PubMed |
| 40197964 | Infectivity studies of Leishmania (Leishmania) infantum chagasi isolated from non-ulcerated cutaneous leishmaniasis. | Rev Inst Med Trop Sao Paulo | 2025 | https://conductscience.org/library/papers/40197964 | PubMed |
| 40131505 | CRISPR/Cas9-mediated deletion of a kinetoplast-associated gene attenuates virulence in Leishmania major parasites. | Med Microbiol Immunol | 2025 | https://conductscience.org/library/papers/40131505 | PubMed |
| 40096189 | Leishmania major Dihydrolipoyl dehydrogenase (DLD) is a key metabolic enzyme that drives parasite proliferation, pathology and host immune response. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/40096189 | PubMed |
| 39502693 | Leishmania major surface components and DKK1 signalling via LRP6 promote migration and longevity of neutrophils in the infection site. | Front Immunol | 2024 | https://conductscience.org/library/papers/39502693 | PubMed |
| 39482311 | CYP5122A1 encodes an essential sterol C4-methyl oxidase in Leishmania donovani and determines the antileishmanial activity of antifungal azoles. | Nat Commun | 2024 | https://conductscience.org/library/papers/39482311 | PubMed |
| 39457604 | Compared Antileishmanial Activity of Clomiphene and Tamoxifen. | Biomedicines | 2024 | https://conductscience.org/library/papers/39457604 | PubMed |
| 39456689 | Molecular Characterization of Sterol C4-Methyl Oxidase in Leishmania major. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39456689 | PubMed |
| 39387580 | Can letrozole be repurposed for the treatment of visceral leishmaniasis? | Antimicrob Agents Chemother | 2024 | https://conductscience.org/library/papers/39387580 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3877902
GET https://conductscience.org/api/papers/v1/3877902/cited_by?page=2